HNN3.0
Register
Register
Register

Digimevo

Company (SME)

digimevo.com/Barcelona, Spain

About

Digimevo is a digital health company at the intersection of clinical expertise, technology, and precision medicine. Founded by physicians and healthcare innovators, Digimevo develops interoperable platforms that integrate clinical, behavioural, and biological data to deliver personalised prevention, monitoring, and management solutions for chronic and neurodegenerative diseases.

The company leverages artificial intelligence, machine learning, and predictive analytics to transform complex health data into actionable insights, supporting clinicians and patients in proactive decision-making. Digimevo’s solutions emphasize patient engagement, co-creation, and accessibility, ensuring interventions are effective, equitable, and scalable across diverse populations.

Current initiatives include digital platforms for personalised risk assessment, monitoring mitochondrial and metabolic health, early detection of neurodegenerative vulnerability, and tools for managing chronic conditions through AI-driven guidance and continuous feedback. The company actively collaborates with hospitals, research centers, and industry partners to advance translational research and deliver evidence-based digital therapeutics.

By combining medical expertise with technological innovation, Digimevo aims to contribute to the European vision of precision and proactive healthcare, demonstrating scalable, patient-centered approaches that improve outcomes, reduce healthcare inequalities, and accelerate the adoption of advanced health data solutions across Europe.

Social media

Representatives

Consultant International project manager

Digimevo

Marketplace (1)

  • Project cooperation

    Partner looking for consortium

    Digimevo | Point-of-Care Digital Therapeutics (DTx), Patient Engagement & Real-World Data (RWE) Platform

    • Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
    • Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
    • Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
    • Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
    • Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
    • Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
    Author

    Consultant International project manager at Digimevo

    Barcelona, Spain